Stay updated on Belantamab Dosing Regimens in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Belantamab Dosing Regimens in Multiple Myeloma Clinical Trial page.

Latest updates to the Belantamab Dosing Regimens in Multiple Myeloma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded Revision: v3.3.3 to the history; removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedRevision history shows the addition of version v3.3.2 and the removal of version v3.2.0 in the page's record history, which are minor metadata updates that do not affect study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedRemoved the site-wide government funding and operating status notice that previously appeared at the top of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check61 days agoChange DetectedThe latest version shows a UI refresh of the Record History page with no changes to core trial data (status, enrollment, or outcomes). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page now shows a newer date and indicates results are posted, adding detailed Outcome Measures and Results (from 2025-09-18) while removing the previous status of Results Submitted, signaling a transition from submission to posting.SummaryDifference2%

- Check90 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference11%

Stay in the know with updates to Belantamab Dosing Regimens in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Dosing Regimens in Multiple Myeloma Clinical Trial page.